Tralokinumab: Exploring the Potential of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a novel approach for chronic dermatitis. This humanized antibody inhibits IL-13, a https://mediajx.com/story28090683/text